Impact of Gestational Age and Birth Weight on Amikacin Clearance on Day 1 of Life | Zendy

Michiel F. Schreuder | Zendy; Abraham J. Wilhelm | Zendy; Arend Bökenkamp | Zendy; Simone M.H. Timmermans | Zendy; Henriëtte A. Delemarrevan de Waal | Zendy; J. A. E. van Wijk | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Impact of Gestational Age and Birth Weight on Amikacin Clearance on Day 1 of Life

Author(s) -

Michiel F. Schreuder,

Abraham J. Wilhelm,

Arend Bökenkamp,

Simone M.H. Timmermans,

Henriëtte A. Delemarrevan de Waal,

J. A. E. van Wijk

Publication year - 2009

Publication title -

clinical journal of the american society of nephrology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.755

H-Index - 151

eISSN - 1555-905X

pISSN - 1555-9041

DOI - 10.2215/cjn.02230409

Subject(s) - medicine , amikacin , gestational age , birth weight , population , renal function , pediatrics , low birth weight , obstetrics , pregnancy , antibiotics , environmental health , biology , microbiology and biotechnology , genetics

Intrauterine growth restriction (IUGR) and prematurity are associated with a low nephron endowment. It can therefore be expected that neonates who are born premature and/or after IUGR have a lower GFR. Measurement of GFR in neonates is difficult, but the clearance of amikacin has been proven to be a reliable marker. We hypothesized that amikacin clearance is lower after IUGR or premature birth as a marker of low nephron endowment.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research